Neuromuscular junction (NMJ) disorders include several dysfunctions that ultimately lead to
muscle weakness. Myasthenia gravis (MG) is the most prevalent NMJ disorder with a highly …

Autoimmune neuromuscular junction disorders are rare. However, myasthenia gravis is
being increasingly recognised in people older than 50 years. In the past 5–10 years …

Myasthenia gravis (MG) is an archetypal autoimmune disease. The pathology is
characterized by autoantibodies to the acetylcholine receptor (AChR) in most patients or to …

Myasthenia gravis (MG) is a prototypical B cell-mediated autoimmune disease affecting 20–
50 people per 100,000. The majority of patients fall into two clinically distinguishable types …

Myasthenia gravis (MG) is a rare, chronic autoimmune disease with symptoms of fluctuating
muscular weakness and fatigability. The aim of this retrospective cohort study was to …

Alteration in onset-age distribution in myasthenia gravis (MG) and its increasing prevalence
among the elderly underscores the need for a better understanding of the clinical course of …

Objectives: A number of worldwide studies have highlighted a rising incidence of
myasthenia gravis (MG) over the past few decades. This is largely due to an increase in …

Myasthenia Gravis (MG) is an autoimmune disease with several comorbidities, however
information on MG mortality remains sparse. We conducted a nationwide register-based …

Objective This is the first cross-region epidemiological study of myasthenia gravis (MG) in
China. We estimated the incidence, prevalence, and medical costs of MG in southern China …

Background/objectives While the clinical manifestations of myasthenia gravis (MG) are well
understood, its humanistic impact is not. The objective of this systematic literature review …